Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients

NCT00454272 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

197

Enrollment

INDUSTRY

Sponsor class

Conditions

Infection
Febrile Neutropenia

Interventions

DRUG: Teicoplanin
DRUG: Vancomycin

Sponsor

Sanofi